No Data
No Data
Insulet Shares Are Trading Higher Amid Strength in Diabetes-related Stocks Following Weight Loss Data From Novo Nordisk.
DexCom, Insulet, Tandem Benefit From Novo Nordisk CagriSema Data
Executive VP Of Insulet Sold 26% Of Their Shares
Insulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its Industry
Unusual Options Activity: DVN, GOOGL and Others Attract Market Bets, DVN V/OI Ratio Reaches 78.9
EST Dec 16th Closing Delivery - In the last three hours of trading, 7 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Insulet Is Maintained at Overweight by JP Morgan